Abstract:Objective: To demonstrate the potential utility of dedicated neurosonography for the diagnosis of fetal brain involvement in tuberous sclerosis complex. Methods: This was a multicenter retrospective study of fetuses at high risk for tuberous sclerosis complex. Dedicated neurosonographic, fetal magnetic resonance imaging (MRI) and postnatal reports were reviewed. Data collected included reason for referral, gestational age at which cardiac rhabdomyoma was first suspected and final number of cardiac rhabdomyomas detected on dedicated imaging. We searched for tuberous sclerosis complex-related brain involvement, defined as the presence of one or more of the following findings: white-matter lesions; subependymal nodules; cortical/subcortical tubers; and subependymal giant-cell astrocytoma. Results: We included 20 patients at high risk of tuberous sclerosis complex, of whom 19 were referred for the presence of cardiac rhabdomyomas and one for a deletion in chromosome 16 involving the tuberous sclerosis complex gene locus. Cardiac rhabdomyomas were diagnosed at a mean gestational age of 27 + 2 weeks (range, 16 + 0 to 36 + 3 weeks) and the mean number of cardiac rhabdomyomas per patient was 4 (range, 1-10). Brain involvement was present in 15 fetuses, in 13 of which the disease was confirmed in one or more of the following ways: chromosomal microarray analysis (n = 1), exome sequencing (n = 7), autopsy (n = 4), clinical tuberous sclerosis complex in the newborn (n = 4) and a sibling diagnosed with clinical tuberous sclerosis complex (n = 1). In two cases, the disease could not be confirmed: one was lost to follow-up and autopsy, following termination of pregnancy, was not performed in the other. Among the five cases without brain findings, tuberous sclerosis complex was confirmed in three by exome sequencing (n = 2) and/or autopsy findings (n = 2). The two remaining cases had normal exome sequencing; one case had five cardiac rhabdomyomas, which was a highly suggestive finding, while in the final case, the autopsy was considered normal, representing the only false-positive case in our cohort. Conclusions: Contrary to current literature, dedicated neurosonography appears to be effective in the diagnosis of brain involvement in fetuses at risk of tuberous sclerosis complex and should be used as the first-line approach. Although the number of cases in which MRI was performed was small, it seems that, in the presence of ultrasound findings, the added value of MRI is low. © 2023 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

OP16.05: Prenatal diagnosis of tuberous sclerosis complex using high-throughput DNA sequencing combined with fetal echocardiography

Antenatal screening and diagnosis of tuberous sclerosis complex by fetal echocardiography and targeted genomic sequencing.

High-throughput sequencing platform established by sensor measurement technology for the detection of TSC1 and TSC2 genes in prenatal diagnosis

Detection of TSC1/TSC2 Mosaic Variants in Patients with Cardiac Rhabdomyoma and Tuberous Sclerosis Complex by Hybrid‐capture Next‐generation Sequencing

Diagnosis of tuberous sclerosis in the prenatal period: a retrospective study of 240 cases and review of the literature

[Genetic Analysis of a Mosaic Case with Low Proportion Mutation of TSC2 Gene].

A large deletion in TSC2 causes tuberous sclerosis complex by dysregulating PI3K/AKT/mTOR signaling pathway

Prenatal Diagnosis and Intervention Improve Developmental Outcomes and Epilepsy Prognosis in Children with Tuberous Sclerosis Complex

[Analysis of Gene Mutation in Patients with Tuberous Sclerosis Complex with Polymerase Chain Reaction-Single Strand Conformation Polymorphism].

The analysis of clinical phenotype and genotype of tuberous sclerosis complex in 105 cases

Delayed diagnosis of tuberous sclerosis complex: unveiling low-level TSC2 mosaicism using targeted next-generation sequencing

Analysis of phenotypic heterogeneity in a family with tuberous sclerosis complex

Prospective Prenatal Cell-Free DNA Screening for Genetic Conditions of Heterogenous Etiologies

Case report：A new foetal sonographic characteristic of Baraitser–Winter cerebrofrontofacial syndrome with ACTB mutation

Prenatal Trio-Based Whole Exome Sequencing in Fetuses with Abnormalities of the Skeletal System

Fetal neurosonography as accurate tool for diagnosis of brain involvement in tuberous sclerosis

Detectionof Fetal Trisomy 8 Mosaicism with Cell-free Fetal DNA in Maternal Plasma

Prenatal diagnosis and clinical management of cardiac rhabdomyoma: a single-center study

Analysis of Clinical Features and Next-Generation Sequencing of 12 Tuberous Sclerosis Families in China

Genotype and Phenotype Analysis of Chinese Children with Tuberous Sclerosis Complex: A Pediatric Cohort Study.

Prenatal diagnosis and intervention improve developmental and epilepsy outcomes in children with tuberous sclerosis